MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
BEAM — Beam Therapeutics Inc. Common Stock
NasdaqBeam Therapeutics Inc. Common Stock
$24.50
+0.11(+0.45%)
- O
- 25.00
- H
- 25.48
- L
- 24.21
- V
- 1.5M
⏱️ End-of-day dataAs of Oct 2, 2026
BEAM — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $28.83M | $29.49M | $26.80M | $28.21M | $52.79M | $28.20M |
| Other Short Term Investments | $92.34M | $95.03M | $80.70M | $86.82M | $69.20M | $56.88M |
| Other Current Assets | $55.30M | $23.48M | $23.58M | $25.13M | $27.66M | $27.41M |
| Total Current Assets | $126.70M | $126.87M | $109.85M | $117.55M | $124.76M | $87.81M |
| Properties | $17.58M | $17.77M | $17.34M | $17.43M | $17.62M | $17.67M |
| Machinery Furniture Equipment | $8.01M | $8.01M | $8.01M | $8.01M | $8.01M | $8.01M |
| Construction In Progress | $3.85M | $2.82M | $10.24M | $7.52M | $3.97M | $2.53M |
| Leases | $11.14M | $11.08M | $10.22M | $10.17M | $10.12M | $10.12M |
| Accumulated Depreciation | $-99.73M | $-94.13M | $-88.60M | $-83.17M | $-77.64M | $-72.11M |
| Other Non Current Assets | $14.45M | $7.31M | $7.25M | $7.30M | $7.52M | $9.40M |
| Total Non Current Assets | $21.38M | $21.25M | $21.25M | $21.57M | $21.93M | $22.57M |
| Total Assets | $148.08M | $148.12M | $131.11M | $139.12M | $146.69M | $110.38M |
| Accounts Payable | $12.29M | $10.23M | $9.54M | $10.56M | $7.70M | $3.87M |
| Accrued Expenses | $23.46M | $23.94M | $23.10M | $27.11M | $21.30M | $18.09M |
| Short Term Debt | $14.78M | $14.36M | $12.69M | $12.95M | $13.21M | $13.47M |
| Deferred Revenue | 304,000.00 | $6.66M | $11.03M | $10.58M | $85.20M | $10.89M |
| Pensions | $6.68M | $29.34M | $16.50M | $11.55M | $5.50M | $21.57M |
| Other Current Liabilities | $17.06M | $12.40M | $10.40M | $6.14M | $8.63M | $16.21M |
| Total Current Liabilities | $74.56M | $96.94M | $18.26M | $17.41M | $14.15M | $18.21M |
| Long Term Debt | $23.60M | $13.98M | $13.87M | $14.19M | $14.49M | $14.80M |
| Other Non Current Liabilities | $5.75M | $6.13M | $6.97M | $1.54M | $1.57M | $1.64M |
| Total Non Current Liabilities | $24.18M | $14.59M | $16.25M | $17.02M | $20.22M | $18.82M |
| Total Liabilities | $31.64M | $24.28M | $34.51M | $34.43M | $34.38M | $37.03M |
| Common Stock | $1.03M | $1.02M | $1.01M | $1.01M | $1.01M | 836,000.00 |
| Retained Earnings | $-173.55M | $-164.12M | $-189.09M | $-177.82M | $-167.59M | $-156.66M |
| Other Shareholders Equity | $-1.07M | $1.11M | 790,000.00 | 10,000.00 | 160,000.00 | 679,000.00 |
| Total Shareholders Equity | $116.44M | $123.84M | $96.60M | $104.68M | $112.31M | $73.35M |
| Additional Paid In Capital | $290.00M | $287.74M | $285.51M | $282.40M | $279.79M | $229.87M |
| Derivative Product Liabilities | N/A | 0.00 | $6.65M | $6.50M | $6.34M | $5.40M |